Martin King retweeted
🩻 #ASCOAI: Could #AI help improve radiation oncology training?
A randomized phase II trial found that AI auto-segmentation improved contour quality and efficiency among novice practitioners performing #ProstateCancer brachytherapy.
Learn more 👉 ascoai.org/articles/2026/10/…
Martin King retweeted
Three-year toxicity data with hyaluronic acid spacer in a randomized hypofractionated prostate RT trial. Martin King, MD, PhD @DanaFarber joins @zklaassen_md @GACancerCenter to discuss three-year toxicity data from the Barrigel™ randomized trial, a two-to-one randomized study of stabilized hyaluronic acid rectal spacer versus no spacer in patients receiving 60 Gray in 20 fractions. #WatchNow > bit.ly/4fjlqoG
Martin King retweeted
Three-year toxicity data with hyaluronic acid spacer in a randomized hypofractionated prostate RT trial. Martin King, MD, PhD @DanaFarber joins @zklaassen_md @GACancerCenter to discuss three-year toxicity data from the Barrigel™ randomized trial, a two-to-one randomized study of stabilized hyaluronic acid rectal spacer versus no spacer in patients receiving 60 Gray in 20 fractions. #WatchNow > bit.ly/4fjlqoG
Martin King retweeted
Register for free for AI in #Brachytherapy. AI is reshaping contouring, planning QA, & workflow in #brachy. Learn practical applications, key safeguards & how emerging tools may shape future training & competency. bit.ly/4niSlLO #medphys #radonc #AIinMedicine
Martin King retweeted
#artificialintelligence is reshaping how #brachy is planned, delivered & taught from contouring & planning to QA & workflow. This webinar covers practical applications, key safeguards & how emerging tools shape future training & competency development. bit.ly/4niSlLO
Martin King retweeted
New randomized data with 10+ years of follow-up shows dose-de-escalated #Pd103 LDR #brachytherapy delivers excellent cancer control with low toxicity for low-risk #prostatecancer.
For patients who choose treatment, the evidence remains strong. bit.ly/4aNedLU
#Urology
Martin King retweeted
Brachytherapy monotherapy for favorable and select unfavorable intermediate risk prostate cancer
nature.com/articles/s41391-0…
This single-institution retrospective analysis of 1,622 men with intermediate-risk #ProstateCancer (median follow-up 10.4 years) evaluated outcomes after brachytherapy with or without androgen deprivation therapy (ADT) and/or external beam radiation therapy (EBRT). Biochemical failure (PSA > 0.4 ng/mL) was more common in patients with PSA ≥10 ng/mL or cT2b-c disease, with 10-year failure rates of 17.2% compared to 5.8% in those without these risk factors. For men with cT1–T2a disease and PSA <10, brachytherapy monotherapy provided excellent long-term control, and neither ADT nor EBRT added benefit. In contrast, among men with higher PSA or cT2b-c tumors, ADT—but not EBRT—reduced the risk of biochemical failure.
These findings suggest brachytherapy monotherapy is well-suited for all favorable intermediate-risk and selected unfavorable intermediate-risk patients who meet cT1–T2a/PSA <10 criteria.
@MtkingMD
@RYYNO10
@MoningiShalini
@peter_orio
@OncoAlert 🚨
@Silke_Gillessen
@AOmlin
@nataliagandur
@bavilima
Martin King retweeted
Throwback to some unforgettable workshop moments! From shared learning & lifelong friendships these snapshots show the heart of the ABS community-where education sparks connection & camaraderie flourishes. Join us in Palm Desert & be part of the experience bit.ly/4m8vC4t
Martin King retweeted
Join us for the Prostate & GYN #brachytherapy Workshop: A Hands-On Approach from Fundamentals to Advanced Practices.
✅ Expert-led sessions
✅ Hands-on training
✅ Tailored tracks for GYN, Prostate & Physics
📍 JW Marriott Desert Springs Resort & Spa
🔗 bit.ly/4m8vC4t
An AI algorithm for measuring tumor volume and prostate volume on MRI can prognosticate both oncologic and toxicity outcomes, respectively, after prostate RT, specifically brachytherapy.
Free link until 5/5.
authors.elsevier.com/c/1kttX…
@RO_GreenJournal @AmericanBrachy
3
89
Martin King retweeted
AI-derived tumor volume from multiparametric MRI and outcomes in localized #ProstateCancer. Martin King & David Yang @BrighamWomens join @zklaassen_md @GACancerCenter to discuss their work demonstrates how their AI model successfully segments and measures prostate tumors from MRI images, showing strong prognostic value for cancer outcomes in both radiation and surgery patients. #WatchNow > bit.ly/4jA76bq
Martin King retweeted
Researchers Drs. Martin King & @DYangMD discuss AI's potential to automate and standardize prostate tumor assessment. Could this revolutionize clinical decision-making in #oncology?
Watch the full discussion on @urotoday - bit.ly/4fNC9O7
Our article on long-term outcomes of the 44/20 and 20/0 randomized trials involving prostate brachytherapy has been published in Practical Radiation Oncology!
authors.elsevier.com/a/1k5Jd…
@AmericanBrachy
Martin King retweeted
The volume of AI-segmented prostatic tumors was an independent prognostic factor for outcomes of localized prostate cancer treated with radical prostatectomy and radiation therapy. @BrighamRadOnc @DYangMD @KatieLeeMDPHD @MtkingMD bit.ly/4hnxfcw
Martin King retweeted
🔍The volume of AI-segmented intraprostatic tumors is an independent prognostic factor for outcomes in localized prostate cancer treated with radical prostatectomy and radiation therapy. Insights from @DYangMD, @KatieLeeMDPHD, @MtkingMD, & @BrighamRadOnc!
pubs.rsna.org/doi/10.1148/ra…
Martin King retweeted
Meet our faculty for #Prostate #Brachytherapy Essentials! Join @MTKingMD @gerard_morton Juanita Crook, and @DrMikeFolkert for Organ at Risk Constraints and Management of Toxicities. Explore cutting-edge advancements to enhance treatment outcomes. bit.ly/3zBBv74
Our manuscript on AI tumor volume for prognosticating outcomes after radiation and surgery has been published in Radiology. A big thanks to the team for getting this work out there!
@BrighamRadOnc @DYangMD @KatieLeeMDPhD
pubs.rsna.org/doi/10.1148/ra…
massgeneralbrigham.org/en/ab…
Martin King retweeted
Are you ready to take your practice to new heights? If so, we have an incredible opportunity that you won't want to miss! Join us for the 2023 Prostate #brachy Workshop. Learn from and collaborate with leading experts in the field. bit.ly/47pGjIV #thisisbrachytherapy
Our work on AI-generated versus clinical prostate contours for ultrasound-based HDR brachytherapy is now published. Basically, observers preferred AI contours for the majority of the cases. Thank you @BrighamRadOnc for your support. @AmericanBrachy
doi.org/10.1002/mp.16716
Article available until mid-October at authors.elsevier.com/a/1hgEc…
Replying to @ASTRO_org
Thank you @IJROBP for publishing our work, the many collaborators for their efforts, and @BrighamRadOnc for making this all possible.
2
116



















